D043169Chemicals & DrugsD12.644.276.100.450.750D12.776.467.100.450.750D12.776.860.300.250.400.537.500D23.529.100.450.750560.998038Endostatinsprns:emailEncryptedemail addressFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonRadiation and Cellular OncologySurgery-General Surgery32049569Rhodes CJAmerican journal of respiratory cell and molecular biologyTargeting Vessel Formation in Pulmonary Arterial Hypertension: Is the Endostatin-Id1-Thrombospondin 1 Pathway a New Hope? Am J Respir Cell Mol Biol. 2020 04; 62(4):411-412.Am J Respir Cell Mol Biol2020-04-01T00:00:002020Targeting Vessel Formation in Pulmonary Arterial Hypertension: Is the Endostatin-Id1-Thrombospondin 1 Pathway a New Hope?12228194Schellens JH, Ratain MJJournal of clinical oncology : official journal of the American Society of Clinical OncologyEndostatin: are the 2 years up yet? J Clin Oncol. 2002 Sep 15; 20(18):3758-60.J Clin Oncol2002-09-15T00:00:002002Endostatin: are the 2 years up yet?Medicine-Hematology and OncologyObstetrics and Gynecology-Urogynecology11079167Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RRCancer journal (Sudbury, Mass.)Antitumor interaction of short-course endostatin and ionizing radiation. Cancer J. 2000 Sep-Oct; 6(5):287-93.Cancer J2000-09-01T00:00:002000Antitumor interaction of short-course endostatin and ionizing radiation.0.1892360.01217575research area of0.3987380.04767286subject area forMargaretMuellerMargaret Mueller41.7886000000000087.598699999999994299Mueller, MargaretAssociate ProfessorUniversity of ChicagoMark J.RatainMark J. Ratain41.78927490000000-87.601250000000001401Ratain, Mark J.ProfessorRalph R.WeichselbaumxXB+DqgWEf/5hHlsaUXv9Gq0+s+oRalph R. Weichselbaum41.78927490000000-87.601250000000002521Weichselbaum, Ralph R.ProfessorNora T.JaskowiakNora T. Jaskowiak41.78927490000000-87.60125000000000487Jaskowiak, Nora T.Professor17071599Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MMThe American journal of pathologyPlatelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am J Pathol. 2006 Nov; 169(5):1767-83.Am J Pathol2006-11-01T00:00:002006Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.ChristopherRhodesChristopher J. Rhodes41.78927490000000-87.60125000000000926Rhodes, ChristopherEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessor1010Medicine-Endocrinology21181203Shantha Kumara HM, Tohme ST, Yan X, Nasar A, Senagore AJ, Kalady MF, Hyman N, Kim IY, Whelan RLSurgical endoscopyPlasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after colorectal cancer surgery. Surg Endosc. 2011 Jun; 25(6):1939-44.Surg Endosc2010-12-22T00:00:002010Plasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after colorectal cancer surgery.